Ona Therapeutics News and Activities

Acquisition, funding and merger involving Ona Therapeutics.

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).

View the org chart displaying its 14 main executives

Most searched biographies at Ona Therapeutics

• Valerie Vanhooren, Chief Executive Officer
• Valerie Calenda, Director
• Joël Jean-Mairet, Director

Create your alert
to follow the executive moves at Ona Therapeutics.

Ona Therapeutics has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Ona Therapeutics

Social media about Ona Therapeutics

• Ona Therapeutics on Wikipedia, Google News & Yahoo Finance
• Ona Therapeutics on LinkedIn, X (Twitter) & YouTube